SCHEMBL14435544

SCHEMBL14435544

O=C1OC[C@@H]2C[C@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1075162 1.00
SCHEMBL13309236 1.00
SCHEMBL3387123 1.00
SCHEMBL21396628 0.87
SCHEMBL6357085 0.87
SCHEMBL13451412 0.84
SCHEMBL6692240 0.84 KDM4E (0.32)
SCHEMBL21185140 0.84
SCHEMBL851839 0.80
SCHEMBL21787940 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924140-A Preparation method of buvaracetam and intermediate thereof 浙江工业大学 2024-04-26 CN disclosed
CN-115340482-A Synthesis method of brivaracetam 四川诺非特生物药业科技有限公司 2022-11-15 CN disclosed
CN-112062740-B Synthesis method of (R) -4-propyl dihydrofuran-2-ketone 深圳市华先医药科技有限公司 2022-11-04 CN disclosed
CN-112062740-B Synthesis method of (R) -4-propyl dihydrofuran-2-ketone 深圳市华先医药科技有限公司 2022-11-04 CN disclosed
WO-2013168002-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS KANDULA MAHESH (IN) 2013-11-14 WO disclosed
WO-2007098356-A1 CONGENERS OF MILNACIPRAN AS MONOAMINE RE-UPTAKE NEUROCRINE BIOSCIENCES, INC. (US) 2007-08-30 WO disclosed